Status:
UNKNOWN
Community Singing Interventions for Postnatal Depression: a Hybrid Type II Effectiveness-implementation Trial
Lead Sponsor:
King's College London
Collaborating Sponsors:
University College, London
Conditions:
Postnatal Depression
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Postnatal depression (PND) affects over 13% of new mothers but there is still not an ideal treatment for all cases. Pharmaceutical and psychotherapy have offered solutions but there are challenges in ...
Detailed Description
Postnatal depression (PND) affects at least 12-15% of new mothers, with symptoms including fatigue, anhedonia, insomnia and irritability. However, challenges surround the fact that there is still no c...
Eligibility Criteria
Inclusion
- Women aged 18 or older
- Satisfactory understanding of English
- Women who have a child between 0 and up to 9 months old
- Women with postnatal depression diagnosed using symptoms of PND at a minimum score of 10 on the Edinburgh Postnatal Depression Scale (EPDS) AND meeting diagnostic criteria for major depressive episode on the Structured Clinical Interview for DSM-IV Disorders (SCID)
- Access to an internet-connected device (mobile phone, tablet, computer or laptop) to allow completion of assessments and participation in the singing sessions.
Exclusion
- Child outside of the age-range specified
- Unable to give informed consent
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04834622
Start Date
September 1 2021
End Date
December 1 2023
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Rd, Brixton, London SE5 9RT
London, United Kingdom, SE5 9RT